Skip to Main Content

In the largest penalty of its kind involving a drug maker, Teva Pharmaceutical agreed to pay more than $519 million to settle civil and criminal charges of violating the Foreign Corrupt Practices Act for bribing foreign government officials in Russia, Ukraine, and Mexico.

Federal authorities alleged that Teva made more than $214 million in illicit profits by making “influential payments” to increase its market share and win regulatory and formulary approvals, as well as favorable drug purchases and prescriptions written by health care providers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!